The Open Source Imaging Consortium (OSIC) and Siemens Healthineers have recently signed a cooperation that aims to achieve rapid advances in the fight against idiopathic pulmonary fibrosis (IPF) and other progressive interstitial lung diseases (ILDs). OSIC is a partnership of academia, industry and philanthropy that is based in Holland, Michigan, USA.
Progressive ILDs are characterized by deteriorating lung function and are usually fatal. Their causes largely remain a mystery. More than 200 different lung diseases are classified in this group, and they affect a large group of individuals: Experts estimate that more than 30,000 people in 27 countries in the EU are diagnosed with idiopathic interstitial lung diseases each year. [1]
